COVID-19 update included
The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic

Global Retinal Surgery Device Market is likely to cross US$ 3 Billion by the end of the year 2024. If we discuss about Retinal diseases, it can be defined as age related macular degeneration. The people with AMD lose vision as the centre of the retina, or macula, degenerates. Retinal diseases are the most common factor around the globe for blindness in developing countries.

Ophthalmic Devices sector as predicted in this report is likely to make a double digit expansion driven by baby boomer aging population as well as Technological advancement. The diseases say for instance cataracts, glaucoma, Diabetic retinopathy as well as AMD continues to cause of vision either radically or totally across the globe.

Renub Research report titled “Retinal Surgery Device Market, Global Forecast by Segments (Retinal Lasers, Vitrectomy Machines, Instruments, Tamponades, Retinal Laser Probes, Hemostasis, Light Pipes, Cryosurgery, Vitrectomy Packs, and Light source & others.) Companies (Alcon Laboratories, Inc., Carl Zeiss, Topcon Corporation, Valeant Pharmaceutical International Inc., Iridex Coporation, Ellex Medical Lasers, Escalon Medical, and Second Sight Medical Products Inc.)”

This report studies the global Retinal surgery device market and volume in-depth and provides an all-encompassing analysis of the key growth factors and preventive factors, market and volume trends, key players and their projections for the future prospects.


Segmentation- Vitrectomy Machines and Retinal Lasers drive the Retinal Surgery Market

On segment basis Global Retinal Surgery Devices is segmented into Instruments, Retinal Lasers, Vitrectomy Machines, Tamponades, Retinal Laser Probes, Hemostasis, Light Pipes, Cryosurgery, Vitrectomy Packs, and Light source & Others. As of projected time frame of 2024, Vitrectomy Machines and Retinal Lasers accounts for the highest market share among all other segments.


Key Players – Retinal Surgery Device Market

This report analysis the key players profile in details like Company Overview, Business Strategy, Merger/Acquisitions as well as Company Sales. In the Global Retinal Surgery Devices market the key players are Alcon Laboratories, Inc., Carl Zeiss, Topcon Corporation, Valeant Pharmaceuticals International, Inc., Iridex Corporation, Ellex Medical Lasers, Escalon Medical and Second Sight Medical Products Inc.


All the 8 companies studied in the report have been studied from 4 points

  • Company Overview
  • Business Strategy
  • Merger/Acquisitions
  • Company Sales



This 90 page report with 42 Figures & Table provides an all-encompassing analysis of the key growth drivers and restraining factors, market trends and their projections for future.


Segments Covered – Retinal Surgery Device Market

  • Retinal Lasers
  • Vitrectomy Machines
  • Instruments
  • Tamponades
  • Retinal Laser Probes
  • Hemostasis
  • Light Pipes
  • Cryosurgery
  • Vitrectomy Packs
  • Light Source & Others




Companies Covered – Retinal Surgery Device Market

  • Alcon Laboratories, Inc.
  • Carl Zeiss
  • Topcon Corporation
  • Valeant Pharmaceuticals International, Inc.
  • Iridex Corporation
  • Ellex Medical Lasers
  • Escalon Medical
  • Second Sight Medical Products Inc.